Page 62 - e-CPG-SLE-8_5_24

Management of Systemic Lupus Erythematosus

of SLE is thus important in deciding the best management approach as
inadequate treatment may lead to significant morbidity and mortality.
Heterogeneity of disease manifestation warrants MDT involvement.
Based on the recommendations in the CPG, the need for specialised
care and certain expensive medications has resource implications that
need to be addressed in the management of SLE.
In line with the key recommendations in this CPG, the following is
proposed as clinical audit indicator for quality management of SLE:
Percentage
of newly Number of newly diagnosed SLE patients
diagnosed prescribed HCQ in a period

X 100%

SLE patients = Total number of newly diagnosed SLE
prescribed patients in the same period
HCQ*
*Target of 90%

Implementation strategies will be developed following the approval of
the CPG by MoH which include Quick Reference and Training Module.

45